Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improved bioavailability from a spironolactone beta-cyclodextrin complex.

N T Yusuff1, P York, H Chrystyn

  • 1Postgraduate School of Studies in Pharmaceutical Technology School of Pharmacy, University of Bradford.

European Journal of Clinical Pharmacology
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of inhaler technique on clinical outcomes in adolescents and adults with asthma: A systematic review.

Respiratory medicine·2022
Same author

Budesonide + formoterol delivered via Spiromax<sup>®</sup> for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler<sup>®</sup>.

Respiratory medicine·2017
Same author

The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries.

BMC health services research·2016
Same author

In vitro aerodynamic characterization of the dose emitted during nebulization of tobramycin high strength solution by novel and jet nebulizer delivery systems.

Pulmonary pharmacology & therapeutics·2016
Same author

Interaction Phenomena in some Aqueous-Based Tablet Coating Polymer Systems.

Pharmaceutical research·2013
Same author

Insula and orbitofrontal cortical morphology in substance dependence is modulated by sex.

AJNR. American journal of neuroradiology·2012
Same journal

Efficacy and safety of Ensitrelvir in COVID-19 patients: a systematic review and meta-analysis with focus on viral clearance and RNA change.

European journal of clinical pharmacology·2026
Same journal

Comparing National Health Technology Assessment approaches and the new European Joint Clinical Assessment framework: The case of onco-hematological medicines.

European journal of clinical pharmacology·2026
Same journal

The efficacy of letrozole in the medical management of ectopic pregnancy: a systematic review and meta-analysis.

European journal of clinical pharmacology·2026
Same journal

Detection of intravenous drug physicochemical incompatibilities in clinical practice: e-Harvis compared to reference tools.

European journal of clinical pharmacology·2026
Same journal

Efficacy and safety of doravirine/islatravir for the treatment of HIV-1: a systematic review and meta-analysis of randomized controlled trials with GRADE assessment.

European journal of clinical pharmacology·2026
Same journal

Critical analysis of digitalis glycosides: declining use but increasing poison-center exposure cases for digitoxin.

European journal of clinical pharmacology·2026
See all related articles

Spironolactone beta-cyclodextrin complex significantly enhances spironolactone bioavailability, increasing it by 233% compared to micronized powder. This formulation shows improved absorption and therapeutic potential for spironolactone delivery.

Area of Science:

  • Pharmacology
  • Pharmaceutics
  • Drug Delivery Systems

Background:

  • Spironolactone is a widely used diuretic and potassium-sparing agent.
  • Poor bioavailability can limit the efficacy of spironolactone.
  • Beta-cyclodextrin complexation is a strategy to improve drug solubility and absorption.

Purpose of the Study:

  • To evaluate the relative bioavailability of spironolactone when formulated as a beta-cyclodextrin complex.
  • To compare the pharmacokinetic profile of the spironolactone-beta-cyclodextrin complex with micronized spironolactone powder and a standard tablet formulation.

Main Methods:

  • A single-dose, double-blind, crossover pharmacokinetic study was conducted in 8 healthy volunteers.
  • Serum canrenone concentrations were measured to assess relative bioavailability.

Related Experiment Videos

  • Comparisons were made between spironolactone beta-cyclodextrin complex, micronized spironolactone powder, and spironolactone tablets (Aldactone).

    • Main Results:

    • The spironolactone beta-cyclodextrin complex demonstrated a mean relative bioavailability of 233% compared to micronized spironolactone powder.
    • Compared to Aldactone tablets, the complex showed 252% relative bioavailability, while micronized powder showed 124%.
    • Area under the serum concentration-time curve (AUC) was significantly higher for the complex.

    Conclusions:

    • Complexation with beta-cyclodextrin significantly enhances the oral bioavailability of spironolactone.
    • The spironolactone-beta-cyclodextrin complex represents a promising formulation for improved spironolactone delivery.
    • Further clinical studies are warranted to confirm the therapeutic implications of this enhanced bioavailability.